Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention-Reference-Cited by-同舟云学术

Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention

Published:2015-05-21 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Mao Chen¹,Fu Xiao-Hong²,Yuan Jin-Qiu²,Yang Zu-Yao¹,Chung Vincent CH³,Qin Ying²,Huang Yafang²,Tam Wilson Wai San⁴,Kwong Joey SW⁵,Xie Wei⁶,Tang Jin-Ling¹

Affiliation:

1. The Chinese University of Hong Kong; Division of Epidemiology, The Jockey Club School of Public Health and Primary Care; Hong Kong SAR China

2. The Chinese University of Hong Kong; Division of Epidemiology, School of Public Health and Primary Care; Shatin Hong Kong New Territories China

3. Chinese University of Hong Kong; Jockey Club School of Public Health and Primary Care; Prince of Wales Hospital Shatin NT, Hong Kong Hong Kong SAR

4. National University of Singapore; Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine; Singapore Singapore

5. West China Hospital, Sichuan University; Chinese Cochrane Center, Chinese Evidence-Based Medicine Center; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

6. School of Chinese Medicine, Southern Medical University; Chinese Medicine; No. 1838 Guangzhou Main North Road Guangzhou Guangdong China 510515

Publisher

Wiley

Subject

Pharmacology (medical)

Reference116 articles.

1. Effect of Tongxinluo capsule on platelet activity and function of vascular endothelium functions as well as prognosis at different stage in patients with acute coronary syndrome after undergoing percutaneous coronary intervention;Chen;South China Journal of Cardiovascular Diseases,2011

2. Effect of Tongxinluo capsule on platelet activities and vascular endothelium functions as well as prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention;Chen;Chinese Journal of Integrated Traditional and Western Medicine,2011

3. Effect of Tongxinluo capsule on platelet activities and vascular endothelium functions at different stages in patients with acute coronary syndrome undergoing percutaneous coronary intervention;Chen;Chinese Pharmaceutical Journal,2012

4. Clinical observation for the effect of Tong-xin-luo capsules in preventing restenosis in patients with coronary heart disease after percutaneous coronary intervention;Dai;Guangming Journal of Chinese Medicine,2011

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of eight oral Chinese patent medicines for dilated cardiomyopathy with heart failure: a Bayesian network meta-analysis;Systematic Reviews;2024-08-31

2. The efficacy of traditional Chinese herbal medicine across multiple cardiovascular diseases: an umbrella review of systematic reviews of randomized controlled trials;Journal of Cardiovascular Pharmacology;2024-01-09

3. Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials;Frontiers in Pharmacology;2024-01-05

4. Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine;Chinese Journal of Integrative Medicine;2023-05-18

5. The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms;Acta Pharmaceutica Sinica B;2023-05